Does the Brain Release DMT at Death? What Science says

Few ideas in popular neuroscience capture the imagination quite like the belief that your dying brain floods itself with DMT. For decades, pop culture and spiritual communities claimed this powerful psychedelic molecule orchestrates the tunnel of light, out-of-body sensations, and peaceful visions reported by cardiac arrest survivors. But what does actual laboratory data say when we look under the hood of a dying mammalian brain?

The birth of the “Spirit Molecule” hypothesis

Where did this idea actually come from?

Neural activity and human consciousness. Source: Naeblys / Getty Images

In the 1990s, psychiatrist Dr. Rick Strassman conducted groundbreaking clinical trials with N,N-Dimethyltryptamine (DMT) at the University of New Mexico. Volunteers given intravenous DMT consistently reported profound mystical encounters: dissolving ego boundaries, entering luminous geometric landscapes, and communicating with sentient, otherworldly entities.

Strassman noticed unmistakable parallels between these drug-induced visions and the stories told by people who survived clinical death.

In his 2001 book DMT: The Spirit Molecule, Strassman floated a hypothesis: what if the human pineal gland — a tiny, pinecone-shaped structure deep in the brain responsible for making melatonin — synthesizes and dumps huge quantities of DMT during moments of extreme trauma, birth, and death?

It sounded intuitive. It matched ancient philosophical folklore that treated the pineal gland as the “third eye” or the “seat of the soul”.

There was just one catch: Strassman had no hard biological proof at the time. It was an educated guess, yet the internet took it as established fact.

Chemical reality check: can the pineal gland deliver?

Molecular structure of N,N-Dimethyltryptamine (DMT). Source: Bacsica / Getty Images

For years, mainstream pharmacologists pushed back on the pineal gland theory. Leading the critique was pharmacologist Dr. David Nichols.

Nichols broke down the simple biological math:

• Microscopic Mass: An adult human pineal gland weighs less than 0.2 grams.Its tiny cellular machinery produces around 30 micrograms of melatonin every 24 hours.
• Massive Dose Requirement: To trigger a breakthrough psychedelic experience, the brain needs tens of milligrams of DMT circulating rapidly.
• Aggressive Enzymes: The human body is packed with monoamine oxidase (MAO), an enzyme that shreds DMT molecules almost instantly.

The tiny gland simply does not have the manufacturing capacity to pump out enough DMT to trip before metabolic enzymes wipe it out.

Case closed? Not quite.

University of michigan breakthrough: Jon Dean & Jimo Borjigin

In 2019, a landmark study published in Scientific Reports flipped the script. Neurophysiologist Dr. Jimo Borjigin and graduate researcher Jon Dean at the University of Michigan made two major discoveries that transformed how neuroscientists view endogenous psychedelics:

1. The brain doesn’t need the pineal gland to make dmt

Using advanced gene-mapping techniques, the Michigan team looked for the two specific enzymes needed to assemble DMT: INMT (indolethylamine N-methyltransferase) and AADC (aromatic L-amino acid decarboxylase).

They found mRNA for these enzymes expressed not just in the pineal gland, but across the cerebral cortex and the hippocampus — the brain’s command centers for conscious perception and memory. When they surgically removed the pineal gland in rats, the brain kept manufacturing DMT just fine.

2. Extracellular DMT surges during cardiac arrest

Using microdialysis probes, the researchers measured real-time chemical changes in rodent brains while inducing experimental cardiac arrest.

The data was striking: when the heart stopped and oxygen vanished, extracellular levels of DMT spiked significantly in the brain’s visual cortex, alongside surges in serotonin and dopamine.

Does this prove your dying brain gets high on DMT?

Hold your horses. While the surge was real, the absolute concentrations remained in the nanomolar range. That is orders of magnitude lower than the micromolar levels needed to fully activate the 5-HT2A serotonin receptors that cause psychedelic hallucinations. The surge might be an evolutionary neuroprotective reflex, or simply a frantic neurochemical alarm signaling cellular distress.

DMT trips vs Near-death experiences: do they truly match?

In 2018, researchers at Imperial College London led by Dr. Chris Timmermann ran the first direct clinical comparison between DMT experiences and Near-Death Experiences (NDEs).

They gave 13 healthy volunteers intravenous DMT and scored their visions against the Greyson NDE Scale — the gold standard metric used by doctors to evaluate real-life near-death events.

Experiential Overlap Matrix

Every single participant on DMT scored high enough on the Greyson scale to qualify as having had an actual near-death experience.

Yet, when you look closely at the subjective reports, key differences emerge:

• Visual Style: DMT visions are famously hyper-colored, chaotic, geometric, and packed with complex multidimensional fractal architecture. Real NDEs tend to be narrative, autobiographical, and visually realistic (like walking into a bright field or seeing a deceased family member).
• Life Reviews: People experiencing true NDEs frequently report a panoramic, moral playback of their entire lives. DMT users rarely report this.
• Auditory Tones: DMT users almost universally report a distinct high-pitched carrier whine at onset. NDE survivors rarely describe that specific sound.

EEG brain wave patterns, highlighting Gamma waves. Source: Magis Center

What else happens in the dying brain? Real neuroscience

If DMT isn’t solely responsible for the visions of the dying, what is?

Modern clinical neuroscience points to a cascade of distinct neurophysiological events that create the classic NDE experience:

1. The Dying Gamma Surge: In 2023, Dr. Borjigin’s team at Michigan recorded EEG data from comatose patients being removed from life support. When oxygen stopped flowing, they observed an intense burst of synchronized high-frequency gamma waves (30 – 150 Hz) in the brain’s temporo-parieto-occipital junction. Gamma waves are associated with heightened awareness, active memory recall, and lucid dreaming. The dying brain may experience a final flash of hyper-conscious processing right before clinical flatline.
2. The “Tunnel of Light” (Retinal Hypoxia): As cardiac output drops, blood flow to the eyes slows down. Peripheral vision degrades first because rods and cones on the edges of your retina run out of oxygen before the center does. The result is literal tunnel vision fading toward central light.
3. Out-of-Body Sensations (TPJ Disruption): The temporoparietal junction (TPJ) integrates your vision, balance, and touch to build your brain’s internal map of where your body sits in space. When the TPJ is deprived of oxygen or stimulated electrically, that spatial mapping fails, creating the illusion of floating above yourself.
4. Endorphin and Endocannabinoid Floods: Under extreme trauma, the brain unleashes massive reserves of endogenous opioids to blunt agony, explaining the overwhelming wave of calm, warmth, and euphoria survivors recall.

(To explore the pharmacological arguments against the pineal gland theory, watch David Nichols’ lecture on DMT and the Pineal Gland. This talk directly addresses the biochemical capacity of the human brain to synthesize DMT and details why the original pineal hypothesis required scientific revision.)

Myth, fact, or something in between?

So, does your brain release DMT when you die?

The current scientific consensus sits on nuanced ground:

• Endogenous DMT is real: The mammalian brain possesses the cellular machinery to produce DMT across major cortical regions, and levels do elevate during cardiac arrest in animal models.
• The Pineal Gland myth is outdated: The pineal gland is not a pressurized DMT tank waiting to burst; cortical neurons are where the real synthesis happens.
• DMT alone does not explain NDEs: The amount produced appears too small to single-handedly trigger a full-blown trip.

Rather than a single chemical “hallucination drug,” near-death experiences appear to be the grand finale of a complex symphony — a combination of coordinated gamma wave surges, sensory disinhibition, neuroprotective neurochemicals, and receptor cascades working together in the brain’s final moments.